Article
Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.
Schizophrenia bulletin - 1 Mar 2010
van den Buuse Maarten
Abstract excerpt
In recent years, there have been huge advances in the use of genetically modified mice to study pathophysiological mechanisms involved in schizophrenia. This has allowed rapid progress in our understanding of the role of several proposed gene mechanisms in schizophrenia, and yet this research has also revealed how much still remains unresolved. Behavioral studies in genetically modified mice are reviewed with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
